Using spectral flow cytometry, we assessed the frequencies of Eomes+ and T-bet+ cells among CD3+ cells, CD56neg CD16+ and conventional NK cells from PBMCs of HV (N=16) and AML patients (N=7) with CD56neg CD16+ NK cells expansion at diagnosis (Expanded group). Here, EOMES is linked to acute myeloid leukemia.